↓ Skip to main content

Mesenchymal stromal cells as vehicles of tetravalent bispecific Tandab (CD3/CD19) for the treatment of B cell lymphoma combined with IDO pathway inhibitor d-1-methyl-tryptophan

Overview of attention for article published in Journal of Hematology & Oncology, February 2017
Altmetric Badge

Mentioned by

twitter
4 X users

Citations

dimensions_citation
57 Dimensions

Readers on

mendeley
44 Mendeley